155 related articles for article (PubMed ID: 7831795)
1. Structure and biological activity of the subgenomic Mtv-6 endogenous provirus.
Cho K; Ferrick DA; Morris DW
Virology; 1995 Jan; 206(1):395-402. PubMed ID: 7831795
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of the effects of Mtv-2 on the T cell repertoire in the WXG-2 mouse strain.
Ferrick DA; Cho K; Gemmell-Hori L; Morris DW
Int Immunol; 1992 Jul; 4(7):805-10. PubMed ID: 1323327
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
4. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP
J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution of Mtv-7-like exogenous retroviral transcripts and clonal deletion of V beta 6+ T cells in Mls-1b BALB/c mice.
Desaymard C; Tucek CL; Rocha B; Korman AJ; Papiernik M
Int Immunol; 1993 Feb; 5(2):217-22. PubMed ID: 8383996
[TBL] [Abstract][Full Text] [Related]
6. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7.
Rudy CK; Kraus E; Palmer E; Huber BT
J Exp Med; 1992 Jun; 175(6):1613-21. PubMed ID: 1316931
[TBL] [Abstract][Full Text] [Related]
7. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
Xu L; Wrona TJ; Dudley JP
Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
[TBL] [Abstract][Full Text] [Related]
8. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.
Waanders GA; Shakhov AN; Held W; Karapetian O; Acha-Orbea H; MacDonald HR
J Exp Med; 1993 May; 177(5):1359-66. PubMed ID: 8386743
[TBL] [Abstract][Full Text] [Related]
9. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
Wrona TJ; Lozano M; Binhazim AA; Dudley JP
J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
Waanders GA; Lees RK; Held W; MacDonald HR
Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
[TBL] [Abstract][Full Text] [Related]
11. A novel V beta 2-specific endogenous mouse mammary tumor virus which is capable of producing a milk-borne exogenous virus.
Niimi N; Wajjwalku W; Ando Y; Nakamura N; Ueda M; Yoshikai Y
J Virol; 1995 Nov; 69(11):7269-73. PubMed ID: 7474151
[TBL] [Abstract][Full Text] [Related]
12. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
13. Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens.
Bhadra S; Lozano MM; Payne SM; Dudley JP
PLoS Pathog; 2006 Dec; 2(12):e128. PubMed ID: 17140288
[TBL] [Abstract][Full Text] [Related]
14. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
Foo-Phillips M; Kozak CA; Principato MA; Abe R
J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
[TBL] [Abstract][Full Text] [Related]
16. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.
Nakano H; Yoshimoto T; Kakiuchi T; Matsuzawa A
Eur J Immunol; 1993 Oct; 23(10):2434-9. PubMed ID: 8405042
[TBL] [Abstract][Full Text] [Related]
17. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P
J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928
[TBL] [Abstract][Full Text] [Related]
18. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of Mls-1.
Beutner U; Rudy C; Huber BT
Int Rev Immunol; 1992; 8(4):279-88. PubMed ID: 1318934
[TBL] [Abstract][Full Text] [Related]
20. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
